Sign in
Taking peopleNo phase

KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic Use - Comparing Procalcitonin Kinetics-guided and Absolute Procalcitonin Value-guided Antibiotic Initiation in Reducing Unnecessary Antibiotic Use in Critically Ill Patients

Key facts

Who runs it
Semmelweis University
Where
Hungary2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
250 people, planned
Started
6 Nov 2025
Expected to end
Dec 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Kinetics
  • Absolute
Record updated
3 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Adult (18 years < ) non-surgical, surgical, or trauma patients
  • Suspected new-onset infection on admission or during ICU stay
  • The source of infection is known or highly suspected, and source control has been implemented if needed (i.e., removal of an infected device (e.g., central line, endoprosthesis)
  • Two PCT values are available - one on the day of suspicion of infection and one 24±4 hours earlier
  • Microbiology sampling has to be performed (according to all presumed sources - blood culture -aerobic and anaerobic, lower respiratory tract sample (tracheal aspirate/bronchoalveolar lavage), urine, etc.)
  • Written informed consent of the patient (or legal guardian if the patient cannot provide consent)

Who cannot take part

  • Severe immunosuppression other than steroid use
  • stem-cell transplant recipients
  • solid organ transplant patients
  • Infections for which long-term antibiotic treatment is strongly recommended (e.g., infective endocarditis, osteoarticular infections, chronic prostatitis, tuberculosis)
  • Infections related to primary surgical intervention and adequate source control cannot be guaranteed (e.g., fecal peritonitis, pancreatic necrosectomy, infective necrotizing fascitis - i.e., Fournier's gangrene),
  • Indisputable infections (e.g., hepatic abscess, empyema)
  • Septic shock (hypotension requiring vasopressor therapy to maintain mean blood pressure of 65 mmHg or greater and having a serum lactate level greater than 2 mmol/L after adequate fluid resuscitation)
  • HIV infection with a CD4 count of less than 200 cells/mm3
  • Neutropenia with less than 500 neutrophils/mm3
  • Patients in pregnancy or breastfeeding. Women of childbearing age will be screened by a urine pregnancy test before inclusion in the study
  • Poor chance of survival (i.e., expected ICU stay less than 24 hours or initial Acute Physiology and Health Evaluation Score II (APACHE II) >30)
  • Admissions after cardiopulmonary resuscitation
  • Patients on ABs within 72 hours before inclusion

This trial is currently available in Hungary.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The study aims to compare the efficacy and safety of an absolute procalcitonin (PCT) value-guided antibiotic initiation protocol and a protocol using the kinetics of PCT (the difference between the actual and the previous day value) in hemodynamically stable critically ill patients with suspected new-onset infection on admission or during ICU stay.

Read full original descriptionShow less

The main question it aims to answer:

* Can the investigators decrease the number of unnecessary AB therapies using the kinetics of PCT insted of using absolute PCT values? * Is it safe to use PCT kinetics together with the clinical picture to guide AB initiation? AB therapy will be initiated according to predefined PCT protocols (Kinetics and Absolute Group). After 72 hours of treatment, an independent multidisciplinary team (infectologist, microbiologist and intensivist) will decide about the necessity of the treatment with all the relevant results in hand.

The 2 groups in the trial

  • KineticsTreatment being tested

    In the case of a suspected new-onset infection, the treating physician starts antibiotic therapy according to a predefined protocol depending on the kinetics of PCT.

  • AbsoluteTreatment being tested

    In the case of a new-onset infection, starting ABs is recommended depending on the actual absolute value of PCT.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic Use (KIPRUN) - Protocol for a Multi-center, Randomized, Superiority Trial to Compare the Efficacy and Safety of Procalcitonin Kinetics-guided and Absolute Procalcitonin Value-guided Antibiotic Initiation in Reducing Unnecessary Antibiotic Therapy in Critically Ill Patients
Publications
Record updated
3 November 2026